These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38164121)

  • 1. The Effect of Immunoglobulin G on the Humoral Immunity in Patients with Tuberculosis/HIV Coinfection.
    Matsegora NA; Kaprosh AV; Vasylyeva TI; Antonenko PB; Antonenko K
    AIDS Res Hum Retroviruses; 2024 Apr; 40(4):246-252. PubMed ID: 38164121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of IgG administration on the cellular immunity status in the patients with multidrug-resistant tuberculosis/HIV with CD4 + lymphocyte cells below 50 cells/ μl.
    Matsegora N; Kaprosh A; Antonenko P
    Int J Mycobacteriol; 2021; 10(2):122-128. PubMed ID: 34558462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical value dynamics in patients with multidrug-resistant tuberculosis/hiv with CD4+ lymphocyte cells below 50 cells/μCL and its variability in the application of adjuvant immunoglobulin therapy.
    Matsegora NA; Kaprosh AV; Antonenko PB
    Int J Mycobacteriol; 2019; 8(4):374-380. PubMed ID: 31793509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved Survival and Cure Rates With Concurrent Treatment for Multidrug-Resistant Tuberculosis-Human Immunodeficiency Virus Coinfection in South Africa.
    Brust JCM; Shah NS; Mlisana K; Moodley P; Allana S; Campbell A; Johnson BA; Master I; Mthiyane T; Lachman S; Larkan LM; Ning Y; Malik A; Smith JP; Gandhi NR
    Clin Infect Dis; 2018 Apr; 66(8):1246-1253. PubMed ID: 29293906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug-resistant tuberculosis in an HIV-infected girl.
    Shah I; Mohanty S
    Natl Med J India; 2012; 25(4):210-1. PubMed ID: 23278778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.
    Harausz EP; Garcia-Prats AJ; Law S; Schaaf HS; Kredo T; Seddon JA; Menzies D; Turkova A; Achar J; Amanullah F; Barry P; Becerra M; Chan ED; Chan PC; Ioana Chiotan D; Crossa A; Drobac PC; Fairlie L; Falzon D; Flood J; Gegia M; Hicks RM; Isaakidis P; Kadri SM; Kampmann B; Madhi SA; Marais E; Mariandyshev A; Méndez-Echevarría A; Moore BK; Nargiza P; Ozere I; Padayatchi N; Ur-Rehman S; Rybak N; Santiago-Garcia B; Shah NS; Sharma S; Shim TS; Skrahina A; Soriano-Arandes A; van den Boom M; van der Werf MJ; van der Werf TS; Williams B; Yablokova E; Yim JJ; Furin J; Hesseling AC;
    PLoS Med; 2018 Jul; 15(7):e1002591. PubMed ID: 29995958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment outcomes in multidrug resistant tuberculosis-human immunodeficiency virus Co-infected patients on anti-retroviral therapy at Sizwe Tropical Disease Hospital Johannesburg, South Africa.
    Umanah T; Ncayiyana J; Padanilam X; Nyasulu PS
    BMC Infect Dis; 2015 Oct; 15():478. PubMed ID: 26511616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study.
    Schnippel K; Berhanu RH; Black A; Firnhaber C; Maitisa N; Evans D; Sinanovic E
    BMC Infect Dis; 2016 Oct; 16(1):593. PubMed ID: 27769174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved survival in multidrug-resistant tuberculosis patients receiving integrated tuberculosis and antiretroviral treatment in the SAPiT Trial.
    Padayatchi N; Abdool Karim SS; Naidoo K; Grobler A; Friedland G
    Int J Tuberc Lung Dis; 2014 Feb; 18(2):147-54. PubMed ID: 24429305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of the interval between the initiation of antiretroviral therapy and the initiation of anti-tuberculosis treatment in HIV/tuberculosis-coinfected patients: results from the TREAT Asia HIV Observational Database.
    Han SH; Zhou J; Lee MP; Zhao H; Chen YM; Kumarasamy N; Pujari S; Lee C; Omar SF; Ditangco R; Phanuphak N; Kiertiburanakul S; Chaiwarith R; Merati TP; Yunihastuti E; Tanuma J; Saphonn V; Sohn AH; Choi JY;
    HIV Med; 2014 Feb; 15(2):77-85. PubMed ID: 23980589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse events among HIV/MDR-TB co-infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, India.
    Isaakidis P; Varghese B; Mansoor H; Cox HS; Ladomirska J; Saranchuk P; Da Silva E; Khan S; Paryani R; Udwadia Z; Migliori GB; Sotgiu G; Reid T
    PLoS One; 2012; 7(7):e40781. PubMed ID: 22792406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-Line Antiretroviral Treatment Outcome in HIV-Infected Patients Coinfected with Tuberculosis in Pakistan.
    Shafiq M; Zafar S; Ahmad A; Kazmi A; Fatima A; Mujahid TA; Qazi R; Akhter N; Shahzad A; Rehman SU; Shereen MA; Hyder MZ
    Biomed Res Int; 2023; 2023():4187488. PubMed ID: 37124927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating HIV care and treatment into tuberculosis clinics in Lusaka, Zambia: results from a before-after quasi-experimental study.
    Herce ME; Morse J; Luhanga D; Harris J; Smith HJ; Besa S; Samungole G; Kancheya N; Muyoyeta M; Reid SE
    BMC Infect Dis; 2018 Oct; 18(1):536. PubMed ID: 30367622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of MDR-TB in HIV co-infected patients in Eastern Europe: Results from the TB:HIV study.
    Efsen AMW; Schultze A; Miller RF; Panteleev A; Skrahin A; Podlekareva DN; Miro JM; Girardi E; Furrer H; Losso MH; Toibaro J; Caylà JA; Mocroft A; Lundgren JD; Post FA; Kirk O;
    J Infect; 2018 Jan; 76(1):44-54. PubMed ID: 29061336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcomes and antiretroviral uptake in multidrug-resistant tuberculosis and HIV co-infected patients in Sub Saharan Africa: a systematic review and meta-analysis.
    Chem ED; Van Hout MC; Hope V
    BMC Infect Dis; 2019 Aug; 19(1):723. PubMed ID: 31420021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive-phase treatment outcomes among hospitalized multidrug-resistant tuberculosis patients: results from a nationwide cohort in Nigeria.
    Oladimeji O; Isaakidis P; Obasanya OJ; Eltayeb O; Khogali M; Van den Bergh R; Kumar AM; Hinderaker SG; Abdurrahman ST; Lawson L; Cuevas LE
    PLoS One; 2014; 9(4):e94393. PubMed ID: 24722139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting.
    Gandhi NR; Andrews JR; Brust JC; Montreuil R; Weissman D; Heo M; Moll AP; Friedland GH; Shah NS
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):90-7. PubMed ID: 22236852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical spectrum, risk factors and outcome of immune reconstitution inflammatory syndrome in patients with tuberculosis-HIV coinfection.
    Worodria W; Menten J; Massinga-Loembe M; Mazakpwe D; Bagenda D; Koole O; Mayanja-Kizza H; Kestens L; Mugerwa R; Reiss P; Colebunders R;
    Antivir Ther; 2012; 17(5):841-8. PubMed ID: 22543224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4 cell levels during treatment for tuberculosis (TB) in Ethiopian adults and clinical markers associated with CD4 lymphocytopenia.
    Skogmar S; Schön T; Balcha TT; Jemal ZH; Tibesso G; Björk J; Björkman P
    PLoS One; 2013; 8(12):e83270. PubMed ID: 24358268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential drug-drug interactions between antiretroviral therapy and treatment regimens for multi-drug resistant tuberculosis: Implications for HIV care of MDR-TB co-infected individuals.
    Mukonzo J; Aklillu E; Marconi V; Schinazi RF
    Int J Infect Dis; 2019 Jun; 83():98-101. PubMed ID: 30991140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.